Repligen Corporation Common Stock, RGEN
| RGEN Repligen Corporation Common Stock | 2026-11-20 | -3.81% | v | -1d | 21 | 7446.9m | -13.22% | 2018-11-08 | Biotechnology: Biological Products (No Diagnostic Substances) | Medical Instruments & Supplies |

None
| RGEN Repligen Corporation Common Stock | 2026-11-20 | -3.81% | v | -1d | 21 | 7446.9m | -13.22% | 2018-11-08 | Biotechnology: Biological Products (No Diagnostic Substances) | Medical Instruments & Supplies |
